Literature DB >> 21618078

No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitis.

Hana Hulejová1, Andrea Levitová, Markéta Kuklová, Jan Stochl, Martin Haluzík, Karel Pavelka, Jiří Vencovský, Ladislav Senolt.   

Abstract

To investigate the effect of intensive physiotherapy on disease activity and serum levels of adipocytokines in patients with ankylosing spondylitis (AS). Twenty-six patients with AS were included in this study. Intensive physiotherapy was performed twice a week for a period of 3 months. The Bath AS Disease Activity Index (BASDAI) and the Bath AS Functional Index (BASFI) were assessed at inclusion and after 3 months. Leptin, adiponectin, resistin and visfatin serum levels were analysed by ELISA assays. Patients had mild to moderate disease activity. Baseline levels of adipocytokines did not correlate with indicators of disease activity, functional status or acute-phase reactants. After the 3 months of intensive physiotherapy, BASDAI significantly decreased from 2.98 to 1.8 (p = 0.01) and BASFI improved from 2.31 to 1.37 (p = 0.05), while there were no changes in serum levels of CRP, ESR and adipocytokines. In addition, baseline levels of adipocytokines did not predict the change of disease activity or functional ability. Intensive physiotherapy effectively reduces all clinical measures of disease activity, but it is not associated with a significant change in acute-phase reactants or serum levels of adipocytokines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618078     DOI: 10.1007/s10067-011-1773-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

Review 1.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Nat Rev Immunol       Date:  2006-09-22       Impact factor: 53.106

2.  Impaired endothelial function in patients with ankylosing spondylitis.

Authors:  I Sari; T Okan; S Akar; H Cece; C Altay; M Secil; M Birlik; F Onen; N Akkoc
Journal:  Rheumatology (Oxford)       Date:  2005-10-04       Impact factor: 7.580

3.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

Review 4.  Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity.

Authors:  A Stofkova
Journal:  Endocr Regul       Date:  2010-01

5.  Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities.

Authors:  Fabia Brentano; Olivier Schorr; Caroline Ospelt; Joanna Stanczyk; Renate E Gay; Steffen Gay; Diego Kyburz
Journal:  Arthritis Rheum       Date:  2007-09

6.  Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis.

Authors:  L Senolt; K Pavelka; D Housa; M Haluzík
Journal:  Cytokine       Date:  2006-10-31       Impact factor: 3.861

7.  Comparison of group-based exercise versus home-based exercise in patients with ankylosing spondylitis: effects on Bath Ankylosing Spondylitis Indices, quality of life and depression.

Authors:  Hale Karapolat; Yeşim Akkoc; Ismail Sari; Sibel Eyigor; Servet Akar; Yeşim Kirazli; Nurullah Akkoc
Journal:  Clin Rheumatol       Date:  2007-11-06       Impact factor: 2.980

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

Review 9.  Molecular effects of exercise in patients with inflammatory rheumatic disease.

Authors:  Ingrid E Lundberg; Gustavo A Nader
Journal:  Nat Clin Pract Rheumatol       Date:  2008-10-07

10.  Long-term exercise training in overweight adolescents improves plasma peptide YY and resistin.

Authors:  Terry E Jones; J L Basilio; P M Brophy; M R McCammon; R C Hickner
Journal:  Obesity (Silver Spring)       Date:  2009-02-26       Impact factor: 5.002

View more
  8 in total

1.  Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study.

Authors:  Hana Hulejová; Tereza Kropáčková; Kristýna Bubová; Olga Kryštůfková; Mária Filková; Heřman Mann; Šárka Forejtová; Michal Tomčík; Jiří Vencovský; Karel Pavelka; Ladislav Šenolt
Journal:  Rheumatol Int       Date:  2019-04-25       Impact factor: 2.631

Review 2.  The role of resistin in inflammatory myopathies.

Authors:  Mária Filková; Ladislav Senolt; Jiří Vencovský
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

3.  Adipokine role in physiopathology of inflammatory and degenerative musculoskeletal diseases.

Authors:  Liberato Giardullo; Addolorata Corrado; Nicola Maruotti; Daniela Cici; Natalia Mansueto; Francesco Paolo Cantatore
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 4.  Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.

Authors:  Fernanda Genre; Raquel López-Mejías; José A Miranda-Filloy; Begoña Ubilla; Beatriz Carnero-López; Ricardo Blanco; Trinitario Pina; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Biomed Res Int       Date:  2014-03-18       Impact factor: 3.411

5.  Association of adipokines, interleukin-6, and tumor necrosis factor-α concentrations with clinical characteristics and presence of spinal syndesmophytes in patients with ankylosing spondylitis: A cross-sectional study.

Authors:  Laura Gonzalez-Lopez; Nicte S Fajardo-Robledo; A Miriam Saldaña-Cruz; Inocente V Moreno-Sandoval; David Bonilla-Lara; Soraya Zavaleta-Muñiz; Arnulfo Hernan Nava-Zavala; Paulina Hernandez-Cuervo; Alberto Rocha-Muñoz; Norma Alejandra Rodriguez-Jimenez; Maria L Vazquez-Villegas; J Francisco Muñoz-Valle; Mario Salazar-Paramo; Ernesto G Cardona-Muñoz; Jorge I Gamez-Nava
Journal:  J Int Med Res       Date:  2017-05-23       Impact factor: 1.671

Review 6.  Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  James M Gwinnutt; Maud Wieczorek; Giulio Cavalli; Andra Balanescu; Heike A Bischoff-Ferrari; Annelies Boonen; Savia de Souza; Annette de Thurah; Thomas E Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja Stamm; Karen Walker-Bone; Joep Welling; Mirjana I Zlatković-Švenda; Francis Guillemin; Suzanne M M Verstappen
Journal:  RMD Open       Date:  2022-03

Review 7.  Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases.

Authors:  Morena Scotece; Javier Conde; Rodolfo Gómez; Verónica López; Jesús Pino; Antonio González; Francisca Lago; Juan J Gómez-Reino; Oreste Gualillo
Journal:  Mediators Inflamm       Date:  2012-07-15       Impact factor: 4.711

Review 8.  Adipokines, metabolic syndrome and rheumatic diseases.

Authors:  Vanessa Abella; Morena Scotece; Javier Conde; Verónica López; Verónica Lazzaro; Jesús Pino; Juan J Gómez-Reino; Oreste Gualillo
Journal:  J Immunol Res       Date:  2014-02-26       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.